Cargando…
Understanding Implementation Challenges to Genetic Testing for Familial Hypercholesterolemia in the United States
Cardiovascular disease (CVD) is the leading cause of death in the United States (US), with familial hypercholesterolemia (FH) being a major inherited and genetic risk factor for premature CVD and atherosclerosis. Genetic testing has helped patients and providers confirm the presence of known pathoge...
Autores principales: | Hendricks-Sturrup, Rachele M., Lu, Christine Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463173/ https://www.ncbi.nlm.nih.gov/pubmed/30717118 http://dx.doi.org/10.3390/jpm9010009 |
Ejemplares similares
-
Barriers and Facilitators to Genetic Testing for Familial Hypercholesterolemia in the United States: A Review
por: Hendricks-Sturrup, Rachele M., et al.
Publicado: (2019) -
A Global Review on the Utility of Genetic Testing for Familial Hypercholesterolemia
por: Hendricks-Sturrup, Rachele M., et al.
Publicado: (2020) -
Direct-to-Consumer Genetic Testing Data Privacy: Key Concerns and Recommendations Based on Consumer Perspectives
por: Hendricks-Sturrup, Rachele M., et al.
Publicado: (2019) -
Patient-Reported Outcomes following Genetic Testing for Familial Hypercholesterolemia, Breast and Ovarian Cancer Syndrome, and Lynch Syndrome: A Systematic Review
por: Hendricks-Sturrup, Rachele M., et al.
Publicado: (2021) -
Practical Considerations and Recommendations for “a Revised Hippocratic Oath for the Era of Digital Health”
por: Hendricks-Sturrup, Rachele, et al.
Publicado: (2022)